Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Prostatic Neoplasms 18Burkitt Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large B-Cell, Diffuse 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, B-Cell 4Lymphoma, T-Cell 3Immunoblastic Lymphadenopathy 3Enteropathy-Associated T-Cell Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Blast Crisis 2Vasculitis, Central Nervous System 1Urogenital Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Stiff-Person Syndrome 1Stage II Prostate Adenocarcinoma 1Rasmussen subacute encephalitis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Plasmablastic Lymphoma 1Oropharyngeal Neoplasms 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Neoplasms 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Lymphoma, Follicular 1Lung Neoplasms 1

Interventions

pembrolizumab 2Vorinostat 2Vincristine 2Prednisone 2Doxorubicin 2Cyclophosphamide 2Bortezomib 2prednylidene 1pirarubicin 1etoposide phosphate 1Salvia hispanica seed extract 1Methotrexate 1Ifosfamide 1Everolimus 1Etoposide 1Cholecalciferol 1Brentuximab Vedotin 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Subcutaneous panniculitis-like T-cell lymphoma × prednylidene × Clear all
NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡